BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18036367)

  • 1. Relation of optimal lead positioning as defined by three-dimensional echocardiography to long-term benefit of cardiac resynchronization.
    Becker M; Hoffmann R; Schmitz F; Hundemer A; Kühl H; Schauerte P; Kelm M; Franke A
    Am J Cardiol; 2007 Dec; 100(11):1671-6. PubMed ID: 18036367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of left ventricular lead position in cardiac resynchronization therapy on left ventricular remodelling. A circumferential strain analysis based on 2D echocardiography.
    Becker M; Kramann R; Franke A; Breithardt OA; Heussen N; Knackstedt C; Stellbrink C; Schauerte P; Kelm M; Hoffmann R
    Eur Heart J; 2007 May; 28(10):1211-20. PubMed ID: 17426079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of left ventricular lead position on the efficacy of cardiac resynchronisation therapy: a two-dimensional strain echocardiography study.
    Becker M; Franke A; Breithardt OA; Ocklenburg C; Kaminski T; Kramann R; Knackstedt C; Stellbrink C; Hanrath P; Schauerte P; Hoffmann R
    Heart; 2007 Oct; 93(10):1197-203. PubMed ID: 17309913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M; Bonakdar HR; Jorat MV; Fazelifar AF; Alizadeh A; Ojaghi-Haghjghi Z; Esmaielzadeh M; Sadr-Ameli MA
    Europace; 2009 Mar; 11(3):356-63. PubMed ID: 19136489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of LV lead position in cardiac resynchronization therapy using different imaging modalities.
    Becker M; Altiok E; Ocklenburg C; Krings R; Adams D; Lysansky M; Vogel B; Schauerte P; Knackstedt C; Hoffmann R
    JACC Cardiovasc Imaging; 2010 May; 3(5):472-81. PubMed ID: 20466342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive imaging of cardiac venous anatomy with 64-slice multi-slice computed tomography and noninvasive assessment of left ventricular dyssynchrony by 3-dimensional tissue synchronization imaging in patients with heart failure scheduled for cardiac resynchronization therapy.
    Van de Veire NR; Marsan NA; Schuijf JD; Bleeker GB; Wijffels MC; van Erven L; Holman ER; De Sutter J; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2008 Apr; 101(7):1023-9. PubMed ID: 18359325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
    Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
    Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependency of cardiac resynchronization therapy on myocardial viability at the LV lead position.
    Becker M; Zwicker C; Kaminski M; Napp A; Altiok E; Ocklenburg C; Friedman Z; Adam D; Schauerte P; Marx N; Hoffmann R
    JACC Cardiovasc Imaging; 2011 Apr; 4(4):366-74. PubMed ID: 21492811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy?
    Yu CM; Zhang Q; Yip GW; Chan YS; Lee PW; Wu LW; Lam YY; Kum LC; Chan HC; Chan S; Fung JW
    Am J Cardiol; 2006 Oct; 98(8):1083-7. PubMed ID: 17027576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cardiac resynchronization therapy on left ventricular diastolic filling pattern in responder and nonresponder patients.
    Agacdiken A; Vural A; Ural D; Sahin T; Kozdag G; Kahraman G; Bildirici U; Ural E; Komsuoglu B
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):654-60. PubMed ID: 16008800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA; Bleeker GB; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2007 Dec; 100(11):1665-70. PubMed ID: 18036366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy.
    Ypenburg C; Sieders A; Bleeker GB; Holman ER; van der Wall EE; Schalij MJ; Bax JJ
    Am Heart J; 2007 Dec; 154(6):1160-5. PubMed ID: 18035090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy).
    Kydd AC; Khan FZ; Watson WD; Pugh PJ; Virdee MS; Dutka DP
    JACC Heart Fail; 2014 Jun; 2(3):205-12. PubMed ID: 24952685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.
    Ypenburg C; van Bommel RJ; Borleffs CJ; Bleeker GB; Boersma E; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2009 Feb; 53(6):483-90. PubMed ID: 19195605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Sutton MG; Plappert T; Hilpisch KE; Abraham WT; Hayes DL; Chinchoy E
    Circulation; 2006 Jan; 113(2):266-72. PubMed ID: 16401777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of renal function in patients with cardiac resynchronization therapy.
    Fung JW; Szeto CC; Chan JY; Zhang Q; Chan HC; Yip GW; Yu CM
    Int J Cardiol; 2007 Oct; 122(1):10-6. PubMed ID: 17174419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of contractile reserve for CRT.
    Lim P; Bars C; Mitchell-Heggs L; Roiron C; Elbaz N; Hamdaoui B; Lellouche N; Dubois-Randé JL; Guéret P
    Europace; 2007 Sep; 9(9):739-43. PubMed ID: 17573360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.